Financial Analysis: CVR Medical (OTCMKTS:CRRVF) versus Sight Sciences (NASDAQ:SGHT)

Sight Sciences (NASDAQ:SGHT) and CVR Medical (OTCMKTS:CRRVF) are both small-cap medical companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Profitability

This table compares Sight Sciences and CVR Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Sight Sciences	-63.30%	-47.28%	-32.72%
CVR Medical	N/A	N/A	N/A

Earnings & Valuation

This table compares Sight Sciences and CVR Medical”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Sight Sciences	$79.54 million	2.37	-$55.55 million	($1.02)	-3.65
CVR Medical	N/A	N/A	-$1.82 million	N/A	N/A

CVR Medical has lower revenue, but higher earnings than Sight Sciences.

Analyst Ratings

This is a breakdown of current ratings and target prices for Sight Sciences and CVR Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Sight Sciences	0	5	1	0	2.17
CVR Medical	0	0	0	0	0.00

Sight Sciences currently has a consensus price target of $5.12, suggesting a potential upside of 37.63%. Given Sight Sciences’ stronger consensus rating and higher possible upside, equities analysts clearly believe Sight Sciences is more favorable than CVR Medical.

Insider and Institutional Ownership

55.5% of Sight Sciences shares are owned by institutional investors. 28.9% of Sight Sciences shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Summary

Sight Sciences beats CVR Medical on 6 of the 10 factors compared between the two stocks.

About Sight Sciences

Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. It operates through two segments, Surgical Glaucoma and Dry Eye. The company's products include OMNI Surgical System, an implant-free glaucoma surgery technology indicated to reduce intraocular pressure in adult patients with primary open-angle glaucoma; and SION Surgical Instrument, a manually operated device used in ophthalmic surgical procedures to excise trabecular meshwork. It also offers TearCare System, a wearable eyelid technology for adult patients with evaporative dry eye disease due to meibomian gland dysfunction, as well as related components. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. Sight Sciences, Inc. was incorporated in 2010 and is headquartered in Menlo Park, California.

About CVR Medical

CVR Medical Corp., a healthcare company, engages in the research and development of subsonic, infrasonic, and low frequency sound wave analysis technology for the healthcare sector. The company provides carotid stenotic scan device, a diagnostic tool to detect and measure carotid arterial stenosis. It offers its products for patients, payors, and healthcare providers. CVR Medical Corp. was incorporated in 1980 and is headquartered in North Vancouver, Canada.